Keratinocyte gene transfer and gene therapy

Critical Reviews in Oral Biology and Medicine

Volumn 7, Issue 3, 1996, Pages 204-221

  Garlick, J A ^a   Fenjves, E S ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

epidermal keratinocytes; gene therapy; gene transfer; Oral keratinocytes

Indexed keywords

VIRUS VECTOR;

BIOLISTIC TRANSFORMATION; ELECTROPORATION; EPITHELIZATION; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; KERATINOCYTE; MICROINJECTION; MOUTH MUCOSA; PRIORITY JOURNAL; REPORTER GENE; REVIEW; STEM CELL; TECHNIQUE; WOUND HEALING;

EID: 0029906562     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411960070030101     Document Type: Review

References (138)

1. Albers K, Fuchs E (1987). The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J Cell Biol 105:791-806.
2. Albers KM, Setzer RW, Taichman LB (1986). Heterogeneity in the replicating population of cultured human epidermal keratinocytes. Differentiation 31:134-140.
3. Alexander IE, Russell DW, Miller AD (1994). DNA-damaging agents greatly increase transduction of nondividing cells by adeno-associated virus vectors. J Virol 68:8282-8287.
4. Anderson WF (1992). Human gene therapy. Science 256:808-813.
5. Anderson WF (1993). What about those monkeys that got T-cell lymphoma? Hum Gene Ther 4:1-2.
6. Andreason G, Evans G (1989). Optimization of electroporation for transfection of mammalian cell lines. Anal Biochem 180:3496-3499.
7. Andree C, Swain WF, Page CP, Macklin MD, Slama J, Hatzis D, et al. (1994). In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 91:12188-12192.
8. Aneskievich BJ, Taichman LB (1988). Epithelium-specific response of cultured keratinocytes with infection and adenovirus type 2. J Invest Dermatol 91:309-314.
9. Aneskievich BJ, Letai AG, Fuchs E (1995). Epidermal keratinocytes: Opportunities and applications in somatic cell gene therapy. In: Somatic gene therapy. Chang PL, editor. Boca Raton, FL: CRC Press, pp. 73-90.
10. Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, et al. (1990). Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62:697-708.
11. Baltimore D (1988). Intracellular immunization. Nature 335:395-396.
12. Barra RM, Fenjves ES, Taichman LB (1994). Secretion of apolipoprotein E by basal cells in cultures of epidermal keratinocytes. J Invest Dermatol 102:61-66.
13. Barrandon Y, Green H (1987). Three clonal types of keratinocytes with different capacities for multiplication. Proc Natl Acad Sci USA 84:2302-2306.
14. Barrandon Y, Morgan JR, Mulligan RC, Green H (1989). Restoration of growth potential in paraclones of human keratinocytes by a viral oncogene. Proc Natl Acad Sci USA 86:4102-4106.
15. Bell E, Sher S, Hull B, Merrill C, Rosen S, Chamson A, et al. (1983). The reconstitution of living skin. J Invest Dermatol 81:2s-10s.
16. Benvenisty N, Reshef L (1986). Direct introduction of genes into rats and expression of the genes. Proc Natl Acad Sci USA 83:9551-9555.
17. Blaese RM (1993). Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency. Pediatr Res 33(Suppl):S49-S55.
18. Boyce ST, Ham RG (1983). Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81:33s-40s.
19. Byrne C, Fuchs E (1993). Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Molec Cell Biol 13:3176-3190.
20. Cahianes G, Ho C, Wever R, Williams D, Goeddel S, Leung D (1993). Epstein-Barr virus derived vectors for transient and stable expression of recombinant proteins. BioTech 15:255-259.
21. Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Geddes DM (1995). Liposome-mediated CTFR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1:39-46.
22. Carroll JM, Albers KM, Garlick JA, Harrington R, Taichman LB (1993). Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 90:10270-10274.
23. Chen CA, Okayama H (1989). High-efficiency transformation of mammalian cells by plasmid DNA. Molec Cell Biol 92:2745-2752.
24. Chen Z, Kamath P, Zhang S, Weil MM, Shillitoe EJ (1995). Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18. Cancer Gene Therapy 2:263-271.
25. Cheng L, Ziegelhoffer PR, Yang N-S (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90:4455-4459.
26. Chow LT, Reilly SS, Broker TR, Taichman LB (1987). Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J Virol 61:1913-1918.
27. Clayman GL, Trapnell BC, Mittereder N, Liu T, Eicher S, Zhang S, et al. (1995a). Transduction of normal and malignant oral epithelium by an adenovirus vector: The effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Therapy 2:105-111.
28. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Liu TJ (1995b). In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55:1-6.
29. Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE (1989). Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting: A light electron microscopic and immunohistochemical study. Lab Invest 60:600-612.
30. Cornetta K, Morgan RA, Gillio A, Sturn S, Baltrucki L, O'Reilly R, et al. (1991). No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Hum Gene Ther 2:215-219.
31. Coulombe PA, Hutton ME, Vassar R, Fuchs E (1991). A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J Cell Biol 115:1661-1674.
32. Crystal RG (1995). The gene as drug. Nature Med 1:15-17.
33. Dale BA, Salonen J, Jones AH (1990). New approaches and concepts in the study of differentiation of oral epithelia. Crit Rev Oral Biol Med 1:167-190.
34. Davies J, Jimenez A (1980). A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg 29:1089-1092.
35. de Luca M, Albanese E, Megna M, Cancedda R, Mangiante PE, Cadoni A, et al. (1990). Evidence that human oral epithelium reconstituted in vitro and transplanted onto patients with defects in the oral mucosa retains properties of the original donor site. Transplantation 50:454-459.
36. Deonarain MP, Spooner RA, Epenetos AA (1995). Genetic delivery of enzymes for cancer therapy. Gene Ther 2:235-244.
37. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125-1135.
38. Efstathiou S, Minson AC (1995). Herpes virus-based vectors. Br Med Bull 51:45-55.
39. Evans RM (1988). The steroid and thyroid receptor super-family. Cell 240:889-895.
40. Fahraeus J, Rymo L, Rhum J, Klein G (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449.
41. Fenjves ES, Gordon DA, Pershing LK, Williams DL, Taichman LB (1989). Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: Implications for epidermal function and gene therapy. Proc Natl Acad Sci USA 86:8803-8807.
42. Fenjves ES, Fuchs C, Garlick JA, Williams DL, Taichman LB (1990). Expression of a transfected apolipoprotein E by human squamous carcinoma cells. In: Molecular biology of atherosclerosis. Attie AD, editor. Amsterdam: Elsevier Press, pp. 11-16.
43. Fenjves ES, Smith J, Zaradic S, Taichman LB (1994). Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum Gene Ther 5:1241-1248.
44. Fenjves ES, Yao SN, Kurachi K, Taichman LB (1996). Analysis of loss of expression of a retrovirus-transduced gene in grafted human keratinocytes. J Invest Dermatol 106:576-578.
45. Flowers MED, Stockschlaeder MAR, Schuening FG, Niederwieser D, Hackman R, Miller AD, et al. (1990). Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 87:2349-2353.
46. Friedman AD, Triezenberg SJ, McKnight SL (1988). Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature 335:452-454.
47. Fuchs E (1990). Epidermal differentiation: The bare essentials. J Cell Biol 111:2807-2814.
48. Fuchs E, Esteves RA, Coulombe PA (1992). Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 89:6906-6910.
49. Gallico GG III, O'Connor NE, Compton CC, Kehinde O, Green H (1984). Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311:448-451.
50. Galvin S, Loomis C, Manabe M, Dhouailly D, Sun T-T (1989). The major pathways of keratinocyte differentiation as defined by keratin expression: an overview. Adv Dermatol 4:227-300.
51. Garlick JA (1993). Lineage analysis of keratinocytes in stratified squamous epithelia using retroviral-mediated gene marking (dissertation). Stony Brook, NY: State University of New York at Stony Brook.
52. Garlick JA (1994). Retroviral vectors. In: Keratinocyte methods. Leigh IM, Lane EB, Watt FM, editors. Cambridge: Cambridge University Press, pp. 181-183.
53. Garlick JA, Taichman LB (1993). The fate of genetically marked human oral keratinocytes in vitro. Arch Oral Biol 38:903-910.
54. Garlick JA, Katz AB, Fenjves ES, Taichman LB (1991). Retrovirus-mediated transduction of cultured epidermal keratinocytes. J Invest Dermatol 97:824-829.
55. Garver RI Jr, Goldsmith KT, Rodu B, Hu P, Sorscher EJ, Curiel DT (1994). Strategy for achieving selective killing of carcinomas. Gene Ther 1:46-50.
56. Gerrard AJ, Hudson DL, Brownlee GG, Watt FM (1993). Towards gene therapy for haemophilia B using primary human keratinocytes. Nature (Genet) 3:180-183.
57. Gilboa E, Eglitis MA, Kantoff PW, Anderson WF (1986). Transfer and expression of cloned genes using retrovirus vectors. BioTech 4:504-512.
58. Goff SP (1990). Integration of retroviral DNA into the genome of the infected cell. Cancer Cells 2:172-178.
59. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Weichselbaum RR (1995). Spatial and temporal control of gene therapy using ionizing radiation. Nature Med 1:786-791.
60. Harper JR, Greenhalgh DA, Yuspa S (1988). Expression of transfected DNA by primary murine keratinocytes. J Invest Dermatol 91:150-153.
61. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC (1995). Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nature (Genet) 10:161-166.
62. Hermonat P, Muzyczka N (1984). Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81:6466-6470.
63. Herweijer H, Fritz JD, Hagstrom JE, Wolff JA (1995). Direct gene transfer in vivo. In: Somatic gene therapy. Chang PL, editor, Boca Raton, FL: CRC Press, pp. 183-202.
64. Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, et al. (1993). High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53:2221-2226.
65. Jensen TG, Jensen PKA, Norgard JOR, Bolund L (1990). High-frequency transfection of cultured human epidermal basal cells that differentiate to form a multilayered tissue. Exp Cell Res 189:163-168.
66. Jiang CK, Connolly D, Blumenberg M (1991). Comparison of methods for transfection of human epidermal keratinocytes. J Invest Dermatol 97:969-973.
67. Jones PH, Watt FM (1993). Separation of human epidermal stem cells from transient amplifying cells on the basis of differences in integrin function and expression. Cell 73:713-724.
68. Kasahara N, Dozy AM, Kan YW (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373-1376.
69. Katz AB, Taichman LB (1994). Epidermis as a secretory tissue: An in vitro tissue model to study keratinocyte secretion. J Invest Dermatol 102:55-60.
70. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, et al. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91:7071-7075.
71. Kintner C, Sugden B (1979). The structure of the termini of the DNA of Epstein-Barr virus. Cell 17:661-671.
72. Knowles MR, Hohneker KW, Zhaoqing Z, Olsen JC, Noah TL, Boucher RC (1995). A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831.
73. Kopan R, Traska G, Fuchs E (1987). Retinoids as important regulators of terminal differentiation: Examining keratin expression in individual epidermal cells at various stages of keratinization. J Cell Biol 105:427-440.
74. Kotin RM, Sinisclco M, Samulski RJ, Zhu X, Hunter L, Laughlin CA, et al. (1990). Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211-2215.
75. Langdon J, Williams D, Navsaria H, Leigh I (1991). Autologous keratinocyte grafting: a new technique for intra-oral reconstruction. Br Dent J 171:87-90.
76. Ledley FD (1995). Assessing risk. Hum Gene Ther 6:551-552.
77. Leiden JM (1995). Gene therapy-promises, pitfalls, and prognosis (editorial). N Engl J Med 333:871.
78. Leigh IM, Navsaria H, Purkis PE, McKay I (1991). Clinical practice and biological effects of keratinocyte grafting. Ann Acad Med 20:549-555.
79. Lim K, Chae C-B (1989). A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. BioTech 7:576-579.
80. Lin H, Wells BR, Taylor RE, Birkedal-Hansen H (1987). Degradation of type I collagen by rat mucosal keratinocytes. J Biol Chem 262:6823-6831.
81. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, et al (1995). Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 55:3117-3122.
82. Luger TA, Schwartz T (1990). Evidence for an epidermal cytokine network. J Invest Dermatol 95:100s-104s.
83. MacGregor GR, Mogg AE, Burke JF, Caskey CT (1987). Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidease indicates heterogeneous expression of the bacterial gene. Somat Cell Molec Genet 13:253-265.
84. Mannino RJ, Gould-Fogerite S (1988). Liposome mediated gene transfer. BioTech 6:682-690.
85. Margolskee RF (1992). Epstein-Barr virus based expression vectors. Curr Topics Microbiol Immunol 158:67-96.
86. Mecsas J, Sugden B (1987). Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Ann Rev Cell Biol 3:87-108.
87. Miller AD (1990). Retroviral packaging cells. Hum Gene Ther 1:5-14.
88. Miller AD (1992). Retroviral vectors. Curr Topics Microbiol Immunol 158:3-24.
89. Miller DG, Adam MA, Miller AD (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Molec Cell Biol 10:4239-4242.
90. Morgan JR, Barrandon Y, Green H, Mulligan RC (1987). Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237:1476-1479.
91. Mulligan RC (1993). The basic science of gene therapy. Science 260:926-932.
92. Mungal S, Steinberg BM, Taichman LB (1992). Replication of plasmid-derived HPV11 DNA in cultured keratinocytes. J Virol 66:3220-3224.
93. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989). The E6 and E7 gene of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421.
94. Muzyczka N (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Topics Microbiol Immunol 158:98-129.
95. Nabel GJ, Nabel EG, Yang Z-Y, Fox BA, Plautz GE, Gao X, et al. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307-11311.
96. Nead MA, McCance DJ (1995). Poly-L-ornithine-mediated transfection of human keratinocytes. J Invest Dermatol 105:668-671.
97. Nicolau C, LePape A, Soriano P, Fargette F, Juhel MF (1983). In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc Natl Acad Sci USA 80:1068-1072.
98. Paphadjopoulous D, Heath T, Bragman K, Matthay K (1985). New methodology for liposome targeting to specific cells. Ann NY Acad Sci 446:341-348.
99. Parenteau NL, Nolte CM, Bilbo P, Rosenberg M, Wilkins LM, Johnson EW, et al. (1991). Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 45:245-251.
100. Pellicer A, Robins D, Wold B, Sweet R, Jackson J, Lowy I, et al. (1980). Altering genotype and phenotype by DNA-mediated gene transfer. Science 209:1414-1422.
101. Prigozy T, Dalrymple K, Kedes L, Shuler C (1993). Direct DNA injection into mouse tongue muscle for analysis of promoter function in vivo. Somat Cell Molec Genet 19:111-122.
102. Rheinwald JG (1989). Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In: Cell growth and division; a practical approach. Baserga R, editor. Oxford: IRL Press, pp. 81-94.
103. Roe TY, Reynolds TC, Yu G, Brown PO (1994). Integration of murine leukemia virus depends on mitosis. EMBO J 13:2099-2108.
104. Rorth P, Nerlov C, Blasi F, Johnsen M (1990). Transcription factor PEA3 in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucl Acids Res 18:5009-5017.
105. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, et al. (1991). Adenovirus-mediated transfer of a recombinant l-antitrypsin gene to the lung epithelium in vivo. Science 252:431-434.
106. Russell DW, Miller AD, Alexander IE (1994). Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 91:8915-8919.
107. Sanes JR, Rubenstein JLR, Nicolas JF (1986). Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5:3133-3142.
108. Schlegel R, Phelps WC, Zhang Y-L, Barbosa M (1988). Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J 7:3181-3187.
109. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Krieg T, et al. (1993). Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237-5241.
110. Setoguchi Y, Jaffe HA, Danel C, Crystal RG (1994). Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J Invest Dermtol 102:415-421.
111. Shillitoe EJ, Lapeyre JN, Adler-Storthz K (1994). Gene therapy - its potential in the management of oral cancer. Oral Oncol Eur J Cancer 30(B): 143-154.
112. Siegel G, Bates R, Berns K, Carter B, Kelly D, Kurstak E, et al. (1985). Characteristics and taxonomy of Parvoviridae. Intervirology 23:61-73.
113. Smith L, Foster C, Hitchcock M, Isseroff R (1993). In vitro HPV-11 infection of human foreskin. J Invest Dermatol 101:292-295.
114. Smith P, Bryant E, Kaur P, McDougall J (1989). Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines. Int J Cancer 44:1124-1131.
115. Staedel C, Remy J, Zhongxue H, Broker T, Chow L, Behr J (1994). High-efficiency transfection of primary human keratinocytes with positively charged lipopolyamine: DNA complexes. J Invest Dermatol 102:768-772.
116. Steele C, Shillitoe EJ (1992). Oral virus infections: The potential for gene transfer in treatment and prevention. In: Genetically altered vaccines. Ciardi JE, editor. New York: Plenum Press, pp. 35-42.
117. Steele C, Sacks PG, Adler-Storthz K, Shillitoe EJ (1992). Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Res 52:4706-4711.
118. Steele C, Cowsert LM, Shillitoe EJ (1993). Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res 53:2330-2337.
119. Steinberg BM, Auborn KJ, Brandsma JL, Taichman LB (1989). Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. J Virol 63:957-960.
120. Stockschlaeder MAR, Schuening FG, Graham TC, Storb R (1994). Transplantation of retrovirus-transduced canine keratinocytes expressing the β-galactosidase gene. Gene Ther 1:317-322.
121. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT (1989). Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization and message-specific RNA probes. Virology 172:331-340.
122. Strabinger R, Paphadjopoulos D (1983). Liposomes as carriers for intracellular delivery of nucleic acids. Meth Enzymol 101:512-527.
123. Sugden B, Marsh K, Yates J (1985). A vector that replicates as a plasmid and can be efficiently selected in β-lymphoblasts by Epstein-Barr virus. Molec Cell Biol 5:410-413.
124. Tan TMC, Ting RCY (1995). In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res 55:4599-4605.
125. Temin HM (1990). Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1:111-123.
126. Teumer J, Lindahl A, Green H (1990). Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB J 4:3245-3250.
127. Valera A, Perales JC, Hatzoglou M, Bosch F (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther 5:449-456.
128. Vassar R, Fuchs E (1991). Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Devel 5:714-727.
129. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E (1989). Tissue-specific and differentiation-specific expression of human K14 keratin gene in transgenic mice. Proc Natl Acad Sci USA 86:1563-1567.
130. Vile R, Russell SJ (1994). Gene transfer technologies for the gene therapy of cancer. Gene Ther 1:88-98.
131. Vogt PM, Thompson S, Andree C, Liu P, Breuing K, Hatzis D, et al. (1994). Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA 91:9307-9311.
132. Watt FM, Green H (1982). Stratification and terminal differentiation of cultured epidermal keratinocytes. Differentiation 31:504-507.
133. Weatherall DJ (1995). Scope and limitations of gene therapy. Br Med Bull 51:1-11.
134. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. (1990). Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
135. Yang N-S (1992). Gene transfer into mammalian cells in vivo. Crit Rev Biotechnol 12:335-356.
136. Yang N-S, Sun WH (1995). Gene gun and other non-viral approaches for cancer gene therapy. Nature Med 1:481-483.
137. Yang Y, Trinchieri G, Wilson JM (1995). Recombinant Il-2 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1:890-893.
138. Yu M, Poeschla E, Wong-Staal F (1994). Progress towards gene therapy for HIV infection. Gene Ther 1:13-26.